GOVX vs XYL · $10.6M cap vs P/E 27, rev $4.46B
GeoVax Labs Inc (GOVX) versus Xylem Inc (XYL) — a side-by-side from cached financials, not a winner call.
GeoVax Labs Inc (GOVX) is a biotechnology company listed on US.
Xylem Inc (XYL) is a specialty industrial machinery company listed on NYSE.
Latest reported GOVX revenue for 2026-06-30 was $0. Net income was -$9.7M. GOVX currently screens at market cap $10.6M.
Latest reported XYL revenue for 2026-06-30 was $4.46B. Net income was $456.0M. XYL currently screens at market cap $26.22B and trailing P/E 27.4.
GOVX currently screens at market cap $10.6M. XYL currently screens at market cap $26.22B and trailing P/E 27.4.
Not investment advice. Open the GOVX and XYL stock pages for the full models.
Not investment advice.